Disclaimer: This is an early beta prototype. If you find any error, with data or functionality, please let us know via this page.
Registration date period
Results ordered by trial registration date, descending.
  1. A Single-Dose, Open-Label, Parallel Group Study to Characterize the Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety, and Tolerability of Reslizumab Following Subcutaneous Administration in Children with Asthma (6 to Less Than 12 Years of Age)

    Registration date:
    Status:
    Unknown
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    The primary objective of this study is to evaluate the pharmacokinetics and pharmacodynamics of reslizumab in pediatric patients with asthma 6 to less than 12 years of age following administration of...

    Conditions:
    • Asthma
    Interventions:
    • Reslizumab
  2. Study to evaluate immunogenicity and safety of GSK Biologicals’ measles, mumps, rubella and varicella (MMRV) freezer-stored (MMRVF) & refrigerator-stored (MMRVR) vaccine formulations vs. ProQuad in infants 12-14 months of age when co-administered with hepatitis A and pneumococcal conjugate vaccines

    Registration date:
    Status:
    Unknown
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    • To demonstrate the non-inferiority of GSK Biologicals’ MMRVR co-administered with HAV and PCV compared to ProQuad co-administered with HAV and PCV at Day 42 with respect to - the seroresponse rate...

    Conditions:
    • Healthy volunteers (Use of the candidate MMRV vaccine for immunization of healthy children 12 - 14 months of age against measles, mumps, rubella and varicella)
    Interventions:
    • Havrix 720 Junior
  3. A study to test the pharmacokinetics, efficacy, and safety of brivaracetam in newborns with repeated electroencephalographic seizures. Une étude visant à évaluer la pharmacocinétique, l'efficacité et la sécurité du brivaracetam dans le traitement des crises convulsives électro-encéphalographiques répétées chez les nouveau-nés

    Registration date:
    Status:
    Unknown
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    - To evaluate the pharmacokinetics (PK) of brivaracetam (BRV) in neonates who have seizures that are not adequately controlled with phenobarbital (PB) treatment and to identify the optimum BRV dose...

    Conditions:
    • Electroencephalographic neonatal seizures
    • Crises convulsives électro-encépaholographiques chez les nouveau-nés
    Interventions:
    • BRIVARACETAM
    • Briviact
  4. A trial to evaluate the pharmacokinetics, safety, and tolerability of MK-7655A in children less than 18 years old with confirmed or suspected gram-negative infections

    Registration date:
    Status:
    Unknown
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    To obtain plasma PK data and characterize the PK profile of imipenem, cilastatin, and relebactam (REL) following administration of a single IV dose of IMI/REL in pediatric subjects from birth to less...

    Conditions:
    • Treatment of bacterial infections in pediatric populations
    Interventions:
    • imipenem/cilastatin/relebactam
  5. Roll-over study in patients with TSC and refractory seizures who are judged by the Investigator to benefit from continued treatment with everolimus after completion of study CRAD001M2304

    Registration date:
    Status:
    Unknown
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    To evaluate the long term safety data with everolimus treatment i.e adverse events (AEs) and serious adverse events (SAEs).

    Conditions:
    • Refractory seizures associated with tuberous sclerosis complex
    Interventions:
    • EVEROLIMUS
  6. A Multicenter Open-Label, Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Renally-Impaired Adults with Chronic Hepatitis C Virus Genotype 1 – 6 Infection Πολυκεντρική, Ανοικτή Μελέτη για την Αξιολόγηση της Αποτελεσματικότητας και της Ασφάλειας του Glecaprevir/Pibrentasvir σε Ενήλικες με Νεφρική Δυσλειτουργία με Χρόνια Λοίμωξη με Ιό Ηπατίτιδας C Γονοτύπου 1 – 6

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    To assess the efficacy (by evaluating the percentage of subjects achieving SVR12) and safety of glecaprevir/pibrentasvir (GLE/PIB) in adults with chronic hepatitis C virus (HCV) genotype (GT) 1 – 6...

    Conditions:
    • HCV
    • Ηπατίτιδα C
    Interventions:
    • Glecaprevir/Pibrentasvir
  7. A study to evaluate the effectiveness and safety of study drug (PeproStat) to stop bleeding during surgery. Studija za procjenu djelotvornosti i sigurnosti ispitivanog lijeka (PeproStat) za zaustavljanje krvarenja tijekom kirurškog zahvata

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    The primary objective is to evaluate the efficacy of PeproStat in intraoperative hemostasis in adult subjects who undergo open liver/soft tissue surgery, vascular surgery or spine surgery

    Conditions:
    • To achieve haemostasis when bleeding cannot be controlled by conventional methods alone, such as manual pressure, cauterization, or sutures; or are inappropriate
    Interventions:
    • PeproStat
    • Sodium Chloride 0,9%
  8. A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea. Un estudio clínico para comparar los efectos de cadazolid con vancomicina en niños con Clostridium difficile-asociado a diarrea

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    The primary objective of Part A is to determine the cadazolid dose in children from birth to < 18 years of age by investigating the safety, efficacy, and the systemic and fecal pharmacokinetics (PK)....

    Conditions:
    • Clostridium difficile-asociado a diarrea (CDAD)
    • Clostridium difficile-associated diarrhea (CDAD)
    Interventions:
    • Cadazolid
  9. Study of MK-1986 (tedizolid phosphate) in children 3 mo to <12 yr with acute bacterial skin and skin structure infections (ABSSSI)

    Registration date:
    Status:
    Unknown
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    (1) The primary objective is to use descriptive statistics to evaluate the safety of intravenous (IV) and/or oral 6- or 10-day tedizolid phosphate with 10- or 14-day IV and/or oral comparator in...

    Conditions:
    • acute bacterial skin and skin structure infections (abSSSI)
    Interventions:
    • Flucloxacillin
    • Cefazolin
    • Clindamycin
    • Vancomycin
    • Linezolid
    • Cephalexin
    • TEDIZOLID PHOSPHATE